Citi Maintains Buy On Cipla | Goa Unit Warning Letter Under Scanner#cipla #ciplastocks #brokerageradar #citi #businessnews ...

While Citi has maintained its 'buy' call for Cipla, it noted that a further delay in resolving issues at the Goa facility ...

Investec emphasised the significant potential Cipla holds in the GLP-1 (Glucagon-like peptide) space, a hormone crucial for ...

Goa: Public Works Department Official Confirms ... the company received six inspectional observations in Form 483," the regulatory filing by Cipla Ltd, said. Company Assures To Address All The ...

Margao: Over 2,000 people in need of palliative care and support in South Goa were registered at the Integrated Palliative Care Centre, that operates .

New Delhi, Jan 22 () Drug firm Cipla on Wednesday said it has received observations from the USFDA for its Goa manufacturing facility. It further said that the developments will not have any ...

Cipla share price fell to a fresh 52-week low after the company received 12 observations by USFDA for its manufacturing facility in Goa. "United States Food and Drug Administration (USFDA ...

Drug firm Cipla Ltd on Wednesday said that the US health regulator has issued a warning letter to the company for its manufacturing facility in Goa. "Further to our earlier communication on the ...

Cipla share price fell in early trade today after USFDA issued form 483 for the Goa manufacturing facility of the firm. Cipla share price fell up to 7.74% to Rs 389.55 compared to the previous ...

Citi’s commentary comes as China-based pharma company Jiangsu Hengrui has received approval for Paclitaxel, the generic ...